Incidence of conjunctivitis adverse event in patients treated with biologics for atopic dermatitis: A systematic review and meta-analysis.

Alraddadi, Rose; Alsamadani, Abdulrahman H; Kalantan, Mulham A; Aljefri, Yara E; Maaddawi, Hadeel A; Kadasa, Athoub N; Alturkistani, Rahaf F; Jfri, Abdulhadi H

Alraddadi, Rose; Alsamadani, Abdulrahman H; Kalantan, Mulham A; Aljefri, Yara E; Maaddawi, Hadeel A; Kadasa, Athoub N; Alturkistani, Rahaf F; Jfri, Abdulhadi H.

Afiliación

Alraddadi R; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Alsamadani AH; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Kalantan MA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Aljefri YE; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Maaddawi HA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Kadasa AN; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Alturkistani RF; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Jfri AH; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.

JAAD Int ; 13: 46-47, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37663167

Palabras clave

IL-13; IL-4/13; atopic dermatitis; biologics; dupilumab; lebrikizumab; tralokinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: JAAD Int Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google